<PAGE> 1
-----------------------------
OMB APPROVAL
-----------------------------
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response . . .14.90
-----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)*
FUISZ TECHNOLOGIES LTD.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
359536109
------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SEC 1745 (2/92) Page 1 of 5 pages
---
<PAGE> 2
- ----------------------- --------------------------
CUSIP No. 359536109 13G Page 2 of 5 Pages
- ----------------------- --------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DR. RICHARD C. FUISZ
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
NOT APPLICABLE (A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
4,415,000
SHARES
------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY - 0 -
EACH ------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
REPORTING
4,415,000
PERSON
------------------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
- 0 -
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,415,000
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[x]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
19.7%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
<PAGE> 3
- ----------------------- --------------------------
CUSIP No. 359536109 13G Page 3 of 5 Pages
- ----------------------- --------------------------
SCHEDULE 13G
The information contained herein is filed with respect to the Common
Stock, par value $0.01 per share (the "Stock"), of Fuisz Technologies Ltd. by
Richard C. Fuisz, M.D. ("Dr. Fuisz").
ITEM 1(a). NAME OF ISSUER:
Fuisz Technologies Ltd.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
14555 Avion at Lakeside
Chantilly, Virginia 20151
ITEM 2(a). NAME OF PERSON FILING:
See Cover Page Item 1.
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE:
14555 Avion at Lakeside
Chantilly, Virginia 20151
ITEM 2(c). CITIZENSHIP:
See Cover Page Item 4.
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $0.01 per share
ITEM 2(e). CUSIP NUMBER:
359536109
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b),
OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A:
Inapplicable.
<PAGE> 4
- ----------------------- --------------------------
CUSIP No. 359536109 13G Page 4 of 5 Pages
- ----------------------- --------------------------
ITEM 4. OWNERSHIP.
ITEM 4(a). AMOUNT BENEFICIALLY OWNED:
See Cover Page Item 9. This amount includes 315,000
shares issuable under outstanding stock options
exercisable within 60 days following December 31,
1997. This amount does not include shares
held by the Richard C. Fuisz Children's' Trust, an
irrevocable trust founded for the benefit of the
children of Dr. Fuisz of which Dr. Fuisz is the
grantor. The trustee of the trust is The Bankers
Trust Company. Dr. Fuisz disclaims beneficial
ownership of these shares.
ITEM 4(b). PERCENT OF CLASS:
See Cover Page Item 11.
ITEM 4(c). NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) sole power to vote or to direct the vote:
See Cover Page Item 5.
(ii) shared power to vote or to direct the vote:
See Cover Page Item 6.
(iii) sole power to dispose or to direct the
disposition of:
See Cover Page Item 7.
(iv) shared power to dispose or to direct the
disposition of:
See Cover Page Item 8.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Inapplicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON:
Inapplicable.
<PAGE> 5
- ----------------------- --------------------------
CUSIP No. 359536109 13G Page 5 of 5 Pages
- ----------------------- --------------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
PARENT HOLDING COMPANY.
Inapplicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
GROUP.
Inapplicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Inapplicable.
ITEM 10. CERTIFICATION AND SIGNATURE:
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 13, 1998
- --------------------------
Date
/s/
- -------------------------
Signature
Dr. Richard C. Fuisz
- --------------------------
Name/Title
